Entering text into the input field will update the search result below

Cyclacel Pharmaceuticals jumps on Janney initiation

Sep. 10, 2013 8:28 AM ETCyclacel Pharmaceuticals, Inc. (CYCC) StockCYCCBy: Colin Lokey, SA News Editor
  • Cyclacel Pharmaceuticals (NASDAQ:CYCC) rises 5% premarket (on top of 10% in Monday's regular session) in what looks like a reaction to an initiation (Buy) at Janney Montgomery.
  • Price target is $10.
  • Bullish call is more than likely tied to the company's Phase 3 AML candidate sapacitabine.

Recommended For You

More Trending News

About CYCC Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CYCC--
Cyclacel Pharmaceuticals, Inc.